Bremsstrahlung imaging from the liver using the Monte Carlo simulation

References

• 1.
  Minarik D, Sjgreen-Gleisner K, Linden O, Wingrdh K, Tennvall J, Strand SE, Ljungberg M. 90Y bremsstrahlung imaging for absorbed-dose assessment in high-dose radioimmunotherapy. J Nucl Med 2010; 51: 1974-1978.
• 2.
  Nayak D, Lahiri S. Application of radioisotopes in the field of nuclear medicine. J Radio Nucl Chem 1999; 242: 423-432.
• 3.
  Kowalsky RJ, Falen SW, Kowalsky R. Radiopharmaceuticals in nuclear pharmacy and nuclear medicine: Forrester Center, WVa; American Pharmacists Association; 2004.
• 4.
  Bardis M, Flux G, Lassmann M, Monsieurs M, Savolainen S, Strand SE. Quantitative imaging for clinical dosimetry. Nucl Instrum Methods Phys Res A 2006; 569: 467-471.
• 5.
  Parsai EI, Ayyangar KM, Dobelbower RR, Siegel JA. Clinical fusion of three-dimensional images using bremsstrahlung SPECT and CT. J Nucl Med 1997; 38: 319-324.
• 6.
  Cipriani C, Atzei G, Argir G, Boemi S, Shukla. S, Rossi G, et al. Gamma camera imaging of osseous metastatic lesions by strontium-89 bremsstrahlung. Eur J Nucl Med 1997; 24: 1356-1361.
• 7.
  Siegel JA. Quantitative bremsstrahlung SPECT imaging: attenuation-corrected activity determination. J Nucl Med 1994; 35: 1213-1216.
• 8.
  Assi K, Gardin I, Vera P, Buvat I. Validation of the monte carlo simulator GATE for indium-111 imaging. Phys Med Biol 2005; 50: 3113-3125.
• 9.
  Balachandran S, McGuire L, Flanigan S, Shah H, Boyd C. Bremsstrahlung imaging after 32P treatment for residual suprasellar cyst. Int J Nucl Med Biol 1985; 12: 215-221.
• 10.
  Stabin MG, Eckerman KF, Ryman JC, Williams LE. Bremsstrahlung radiation dose in yttrium-90 therapy applications. J Nucl Med 1994; 35: 1377-1380.
• 11.
  Ito S, Kurosawa H, Kasahara H, Teraoka S, Ariga E, Deji S, et al. 90Y bremsstrahlung emission computed tomography using gamma cameras. Ann Nucl Med 2009; 23: 257-267.
• 12.
  Heard S, Flux GD, Guy MJ, Ott RJ, editors. Monte Carlo simulation of 90Y bremsstrahlung imaging. Nucl Sci Symp Conf Rec IEEE; 2004.
• 13.
  Fabbri C, Sarti G, Cremonesi M, Ferrari M, Dia AD, Agostini M, et al. Quantitative analysis of 90Y bremsstrahlung SPECT-CT images for application to 3D patient-specific dosimetry. Cancer Biother Radiopharm 2009; 24: 145-154.
• 14.
  Stabin M, Flux G. Internal dosimetry as a tool for radiation protection of the patient in nuclear medicine. Biomed Imaging Interv J 2007; 3: e28.
• 15.
  Grevillot L, Bertrand D, Dessy F, Freud N, Sarrut D. GATE as a GEANT4-based Monte Carlo platform for the evaluation of proton pencil beam scanning treatment plans. Phys Med Biol 2012; 57: 4223-4244.
• 16.
  Amako K, Guatelli S, Ivanchencko V, Maire M, Mascialino B, Murakami K, et al. Geant4 and its validation. Nucl Phys B-Proc Suppl 2006; 150: 44-49.
• 17.
  Maigne L, Perrot Y, Schaart DR, Donnarieix D, Breton V. Comparison of GATE/GEANT4 with EGSnrc and MCNP for electron dose calculations at energies between 15 keV and 20 MeV. Phys Med Biol 2011; 56: 811.
• 18.
  Agostinelli S, Allison J, Amako K, Apostolakis J, Araujo H, Arce P, et al. GEANT4a simulation toolkit. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 2003; 506: 250-303.
• 19.
  Barzegar Ziarani M, Bakhshandeh M, bakhshian-Farsani M, Bakhshandeh E, Shakeri N. Review and performance comparison of lead-free shields and lead shields, in terms of biological effects in nuclear medicine by the comet method. Koomesh 2018; 2: 792-799. (Persian).
• 20.
  Tajik-mansoury MA, Taleshi Ahangari H, Rajabi H, Jadidi M. Evaluation of cellular S-value of auger electrons emitting 111In radionuclide by Geant4 and its comparison with MCNP5 Monte Carlo codes and MIRD published data. Koomesh 2019; 21: 567-575. (Persian).